- $522.12m
- $50.73m
- $135.16m
- 51
- 30
- 13
- 22
Annual balance sheet for Prothena, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 295 | 579 | 710 | 619 | 471 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.015 | 0 | — | 5.16 | 0 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 299 | 585 | 719 | 639 | 485 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 20.4 | 14.1 | 8.01 | 16 | 13.8 |
Other Long Term Assets | |||||
Total Assets | 333 | 609 | 758 | 696 | 547 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 25.8 | 33.5 | 50.1 | 56.9 | 48.5 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 149 | 143 | 136 | 135 | 60.2 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 184 | 466 | 622 | 561 | 487 |
Total Liabilities & Shareholders' Equity | 333 | 609 | 758 | 696 | 547 |
Total Common Shares Outstanding |